Tamiflu Lawsuit

Tamiflu Side Effects

Tamiflu, an oseltamivir phosphate capsule used for oral solution, is used for the treatment of simple acute illness as a result of influenza infection in patients older than a year that have had symtoms for more than 2 days.

 Used as a prophylaxis of influenza in patients older than 1 year of age, it should be considered before treatment with Tamiflu is not a substitute for early vaccination yearly. Vaccination is recommended by the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices and can not be replaced by Tamiflu.  Resistance mutations can emerge and could decrease Tamiflu’s effectiveness as a result of the Influenza virus changing over time. Physicans should consider susceptibility patterns and the effects of treatment before deciding on whether to use Tamiflu on a patient.

Tamiflu can be taken with or without food; however, the intake of food with dose can enhance tolerability in some patients.

For the treatment of Influenza in adults and adolescents, 13 years of age or older, the recommended oral dose of Tamiflu is 75mg, twice a day for 5 days. Treatment with Tamiflu should be initiated within 2 days of commencement of symptoms of influenza.

 For the treatment of Influenza in pediatric patients, younger than 1 year of age, the recommended oral dose of Tamiflu is to be defined by the patient’s body weight. If it is not possible for the pediatric patient to swallow a capsule, Tamiflu for oral suspension may also be used. If the Oral suspension is not available, Tamiflu capsules may be opened and mixed in with a sweetened liquid.

Tamiflu Lawsuit

Tamiflu Side Effects

 For the treatment of prophylaxis of Influenza in adults and adolescents, 13 years of age or older, the recommended oral dose of Tamiflu is 75mg, once a day for at least 10 days. Therapy should begin within 2 days of being exposed.

It has not yet been established whether Tamiflu is safe or effective for the treatment of prophylaxis of influenza in pediatric patients.

The FDA has now issued a Public Health Alert advising about the potential dosing errors associated with Tamiflu for Oral Suspension. The problem is that U.S. health care providers usually write prescriptions for liquid medicines in mL or teaspoons, while Tamiflu is dosed in mg. The FDA has received reports of errors because the dosing instructions do not match that of the dosing dispenser. Pharmacist should ensure that the prescription’s units of measure match that of the dosing device provided along with Tamiflu.

Some side effects and adverse reactions associated with the use of Tamiflu include:

aches and pains
rhinorrhea
dyspepsia
upper respiratory tract infections
Nausea
Vomiting
Diarrhea
Abdominal pain
Dizziness
Headache
Cough
Insomnia
Vertigo
Fatigue
Diarrhea
Otitis media
Asthma
Epistaxis
Pneumonia
Ear disorder
Sinusitis
Bronchitis
Conjunctivitis
Dermatitis
Lymphadenopathy
Tympanic membrane disorder
Swelling of the face or tongue
Allergy
anaphylactic/anaphylactoid reactions
Dermatitis
Rash
Eczema
Urticaria
erythema multiforme
Stevens-Johnson Syndrome
toxic epidermal necrolysis
Hepatitis
Cardiac: Arrhythmia
Gastrointestinal bleeding
hemorrhagic colitis
Aggravation of diabetes
Delirium